MedPath
Found 22 clinical trials|View Analysis
Sort by:

A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants

Phase 1
Active, not recruiting
Conditions
Healthy Volunteer
Interventions
Drug: varegacestat
Drug: Itraconazole (200 mg)
First Posted Date
2024-11-07
Last Posted Date
2025-01-07
Lead Sponsor
Immunome, Inc.
Target Recruit Count
22
Registration Number
NCT06677996
Locations
🇺🇸

Celerion, Tempe, Arizona, United States

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

Phase 1
Not yet recruiting
Conditions
Onychomycosis
Interventions
First Posted Date
2024-07-03
Last Posted Date
2024-07-03
Lead Sponsor
Zagazig University
Target Recruit Count
36
Registration Number
NCT06485505

Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

Phase 1
Recruiting
Conditions
Pharmacokinetics
Interventions
First Posted Date
2024-04-23
Last Posted Date
2024-08-09
Lead Sponsor
Modern Biosciences Ltd
Target Recruit Count
48
Registration Number
NCT06379958
Locations
🇬🇧

Celerion, Belfast, United Kingdom

Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects

Phase 1
Completed
Conditions
NSCLC
Interventions
First Posted Date
2023-06-15
Last Posted Date
2024-04-05
Lead Sponsor
Shanghai Henlius Biotech
Target Recruit Count
20
Registration Number
NCT05902728
Locations
🇨🇳

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100

Phase 1
Completed
Conditions
Bacterial Infections
Interventions
Drug: BV100 (300 mg)
Drug: Itraconazole 200 mg
First Posted Date
2023-01-13
Last Posted Date
2023-11-21
Lead Sponsor
BioVersys AG
Target Recruit Count
16
Registration Number
NCT05684718
Locations
🇭🇺

CRU Hungary Kft., Early Phase Unit, Kistarcsa, Hungary

HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI

Phase 1
Completed
Conditions
Relapsed or Refractory Lymphoma
Interventions
First Posted Date
2022-11-02
Last Posted Date
2024-03-06
Lead Sponsor
Hutchmed
Target Recruit Count
59
Registration Number
NCT05602597
Locations
🇺🇸

QPS- Miami, Miami, Florida, United States

A Study to Investigate the Effect of Itraconazole on the Way the Body Absorbs, Distributes, and Gets Rid of ACT-1004-1239 Given as a Single Dose of 10 mg to Healthy Male Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: ACT-1004-1239 (10 mg)
Drug: Itraconazole (200 mg, o.d.)
First Posted Date
2022-09-22
Last Posted Date
2022-11-08
Lead Sponsor
Idorsia Pharmaceuticals Ltd.
Target Recruit Count
16
Registration Number
NCT05549531
Locations
🇵🇹

BlueClinical Phase 1, Porto, Portugal

Mycosis Culture Collection From Dermatological Isolated

Active, not recruiting
Conditions
Nail Diseases
Onychomycosis
Resistant Infection
Interventions
First Posted Date
2022-08-01
Last Posted Date
2024-05-08
Lead Sponsor
University of Rome Tor Vergata
Target Recruit Count
200
Registration Number
NCT05482763
Locations
🇮🇹

Tor Vergata Univerisity Hospital, Rome, Italy

Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers

Phase 1
Completed
Conditions
Achlorhydria
Interventions
First Posted Date
2021-06-28
Last Posted Date
2021-09-29
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
13
Registration Number
NCT04942652
Locations
🇰🇷

Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of

A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis

Phase 3
Completed
Conditions
Chronic Pulmonary Aspergillosis
Interventions
First Posted Date
2021-04-01
Last Posted Date
2024-08-14
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Target Recruit Count
116
Registration Number
NCT04824417
Locations
🇮🇳

Chest clinic, Chandigarh, India

🇮🇳

Respiratory ICU, Department of Pulmonary Medicine, PGIMER, Chandigarh, India

© Copyright 2025. All Rights Reserved by MedPath